[1]
|
de Boer, I.H., Rue, T.C., Hall, Y.N., Heagerty, P.J., Weiss, N.S. and Himmelfarb, J. (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. Journal of the American Medical Association, 305, 2532-2539. doi:10.1001/jama.2011.861
|
[2]
|
Shapo, L., McKee, M., Coker, R. and Ylli, A. (2004) Type 2 diabetes in Tirana city, Albania: A rapid increase in a country in transition. Diabetic Medicine, 21, 77-83.
doi:10.1046/j.1464-5491.2003.01093.x
|
[3]
|
International Diabetes Federation (2012) IDF diabetes atlas [Homepage on the Internet].
http://www.idf.org/diabetesatlas
|
[4]
|
Mongensen, C.E., Keane, W.F., Beneth, P.H., Parving, H.H. and Passa, P. (1995) Prevention of diabetic renal disease with special reference to microalbuminuria and macroalbuminuria. Lancet, 346, 1080-1084.
doi:10.1016/S0140-6736(95)91747-0
|
[5]
|
Jong, P.E., Hillege, H.L., Joan, P.-S. and Zeeuw, D. (2003) Screening for microalbuminuria in the general population: A tool to detect subjects at increased risk for progressive renal failure in an early phase? Nephrology Dialysis Transplantation, 18, 10-13. doi:10.1093/ndt/18.1.10
|
[6]
|
Hiddo, J., Heerspink, L., Holtkamp, F. and Ravid, M. (2011) Monitoring kidney function and albuminuria in patients with diabetes. Diabetes Care, 34, 325-329.
doi:10.2337/dc11-s247
|
[7]
|
de Zeeuw, D., Remuzzi, G. and Parving, H.H. (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL. Kidney International, 65, 2309-2320.
doi:10.1111/j.1523-1755.2004.00653.x
|
[8]
|
Rowe, D.J., Dawnay, A. and Watts, G.F. (1990) Microalbuminuria in diabetic subjects. Annals of Clinical Biochemistry, 27, 297-312.
|
[9]
|
Croal, B.L., Mutch, W.J., Clark, B.M., Dickie, A., Church, J. and Noble, D. (2001) The clinical application of a urine albumin: Creatinine ratio point-of-care device. Clinica Chimica Acta, 307, 15-21.
doi:10.1016/S0009-8981(01)00450-8
|
[10]
|
Marshall, S.M. (1991) Screening for MAU: Which measurement? Diabetic Medicine, 8, 706-711.
doi:10.1111/j.1464-5491.1991.tb01688.x
|
[11]
|
Rowe, D.J., Dawnay, A. and Watts, G.F. (1990) Microalbuminuria in diabetic subjects. Annals of Clinical Biochemistry, 27, 297-312.
|
[12]
|
Amos, A., McCarty, D. and Zimmet, P. (1997) The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Medicine, 14, S1-S85.
doi:10.1002/(SICI)1096-9136(199712)14:5+3.3.CO;2-I
|
[13]
|
Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414, 782-787. doi:10.1038/414782a
|
[14]
|
Ritz, E., Rychlik, I., Locatelli, F. and Halimi, S. (1999) End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. American Journal of Kidney Diseases, 34, 795-808.
doi:10.1016/S0272-6386(99)70035-1
|
[15]
|
Ritz, E. and Orth, S.R. (1999) Nephropathy in patients with type 2 diabetes mellitus. The New England Journal of Medicine, 341, 1127-1133.
doi:10.1056/NEJM199910073411506
|
[16]
|
Parving, H.H. (2001) Diabetic nephropathy: Prevention and treatment. Kidney International, 60, 2041-2055.
doi:10.1046/j.1523-1755.2001.00020.x
|
[17]
|
Verhave, J.C., Gansevoort, R.T., Hillege, H.L., Bakker, S.J., De Zeeuw, D., de Jong, P.E., PREVEND Study Group (2004) An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney International, 66, S18-S21. doi:10.1111/j.1523-1755.2004.09205.x
|
[18]
|
Atkins, R.C., Briganti, E.M. and Lewis, J.B. (2005) Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. American Journal of Kidney Diseases, 45, 281-287.
doi:10.1053/j.ajkd.2004.10.019
|
[19]
|
Bruno, G., Cavallo-Perin, P., Bargero, G., Borra, M., Calvi, V. and D’Errico, N. (1996) Prevalence and risk factors for microand macroalbuminuria in an Italian populationbased cohort of NIDDM subjects. Diabetes Care, 19, 43-47. doi:10.2337/diacare.19.1.43
|
[20]
|
Parving, H.H., Lewis, J.B., Ravid, M., Remuzzi, G. and Hunsicker, L.G. (2006) DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney International, 69, 2057.
doi:10.1038/sj.ki.5000377
|
[21]
|
Toti, F., Bejtja, G., Hoti, K., Shota, E. and Agaci, F. (2007) Poor control and management of cardiovascular risk factors among Albanian diabetic adult patients. Primary Care Diabetes, 1, 81-86. doi:10.1016/j.pcd.2007.04.009
|
[22]
|
Mather, H.M., Chaturvedi, N. and Kehely, A.M. (1998) Comparison of prevalence and risk factors for microalbuminuria in south Asians and European with type 2 diabetes mellitus. Diabetic Medicine, 15, 672-677.
doi:10.1002/(SICI)1096-9136(199808)15:8<672::AID-DIA648>3.0.CO;2-3
|
[23]
|
Retnakaran, R., Cull, C.A., Thorne, K.L., Adler, A.L. and Holman, R.R. (2006) Risk factors for renal dysfunction in type 2 diabetes: UK prospective diabetes study 74. Diabetes, 55, 1832-1839. doi:10.2337/db05-1620
|
[24]
|
Nilsson, P.M., Gudbjornsdottir, S., Eliasson, B., Cederholm, J., Steerng Committee of the Swedish National Diabetes Register (2004) Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes data from the National Diabetes Register in Sweden. Diabetes & Metabolism, 30, 261-268.
doi:10.1016/S1262-3636(07)70117-9
|
[25]
|
Gall, M.A., Rossing, P., Scott, P., Damsbo, P., Vaag, A. and Bech, K. (1991) Prevalence of microand macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 34, 655-661.
doi:10.1007/BF00400995
|
[26]
|
Caramori, M.L., Fioretto, P. and Mauer, M. (2000) The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes, 49, 1399-1408. doi:10.2337/diabetes.49.9.1399
|